Campbell, Anne 
ORCID: 0000-0002-8893-4320, Borek, Aleksandra J ORCID: 0000-0001-6029-5291, McLeod, Monsey ORCID: 0000-0001-5571-2417, Tonkin-Crine, Sarah ORCID: 0000-0003-4470-1151, Pouwels, Koen B ORCID: 0000-0001-7097-8950, Roope, Laurence Sj ORCID: 0000-0001-9098-9331, Hayhoe, Benedict Wj ORCID: 0000-0002-2645-6191, Majeed, Azeem ORCID: 0000-0002-2357-9858, Walker, A Sarah ORCID: 0000-0002-0412-8509, Holmes, Alison ORCID: 0000-0001-5554-5743 et al (show 1 more authors)
(2023)
Impact of the COVID-19 pandemic on antimicrobial stewardship support for general practices in England: a qualitative interview study.
BJGP open, 7 (3).
BJGPO.2022.0193-.
Abstract
<h4>Background</h4>In England, clinical commissioning group (CCG; now replaced by Integrated Care Systems [ICSs]) and primary care network (PCN) professionals support primary care prescribers to optimise antimicrobial stewardship (AMS).<h4>Aim</h4>To explore views and experiences of CCG and PCN staff in supporting AMS, and the impact of COVID-19 on this support.<h4>Design & setting</h4>Qualitative interview study in primary care in England.<h4>Method</h4>Semi-structured interviews with staff from CCG and PCNs responsible for AMS were conducted at two timepoints via telephone. These were audio-recorded, transcribed, and analysed thematically.<h4>Results</h4>Twenty-seven interviews were conducted with 14 participants (nine CCG, five PCN) in December 2020-January 2021 and February-May 2021. The study found that AMS support was (1) deprioritised in order to keep general practice operational and deliver COVID-19 vaccines; (2) disrupted as social distancing made it harder to build relationships, conduct routine AMS activities, and challenge prescribing decisions; and (3) adapted, with opportunities identified for greater use of technology and changing patient and public perceptions of viruses and self-care. It was also found that resources to support AMS were valued if they were both novel, to counter AMS 'fatigue', and sufficiently familiar to fit with existing and/or future AMS.<h4>Conclusion</h4>AMS needs to be reprioritised in general practice in the post-pandemic era and within the new ICSs in England. This should include interventions and strategies that combine novel elements with already familiar strategies to refresh prescribers' motivation and opportunities for AMS. Behaviour change interventions should be aimed at improving the culture and processes for how PCN pharmacists voice concerns about AMS to prescribers in general practice and take advantage of the changed patient and public perceptions of viruses and self-care.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | STEP-UP team |
| Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 29 Sep 2023 09:33 |
| Last Modified: | 24 Nov 2023 11:28 |
| DOI: | 10.3399/bjgpo.2022.0193 |
| Open Access URL: | https://doi.org/10.3399/BJGPO.2022.0193 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3173205 |
Dimensions
Dimensions
